UPDATED: United Therapeutics transitions to public benefit corporation more than 20+ years after IPO
United Therapeutics has been a public company since 1999, but late Thursday the company announced it’s entering a new phase.
United will become a public benefit corporation in what the company claims is the first conversion of a public biotech or pharmaceutical company to PBC, United said. The biotech noted it has previous experience in the PBC world, having run a subsidiary as a public benefit corporation for the past six years.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,300+ biopharma pros reading Endpoints daily — and it's free.